Treatment of Relapsed/Refractory Myeloma (excluding T-cell redirection therapy)
Evaluation of triple-class exposed (TCE) and triple-class refractory (TCR) myeloma patients (pts) and their outcome: A collaborative study of the Argentine Group of Multiple Myeloma (GAMM)
Sergio Lopresti, Hematologist (he/him/his)
Hematologist
Hospital Nacional Alejandro Posadas , Buenos Aires, Argentina